After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Nektar Therapeutics is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Nektar Therapeutics is $303.34M. A total of 36.75 million shares were traded on the day, compared to an average of 242.00K shares.
In the most recent transaction, Zalevsky Jonathan sold 10,712 shares of NKTR for 0.67 per share on May 19 ’25. After the transaction, the Chief R&D Officer now owns 305,892 company shares. In a previous transaction on May 19 ’25, Wilson Mark Andrew sold 9,996 shares at 0.67 per share. NKTR shares that Chief Legal Officer owns now total 314,296.
Among the insiders who sold shares, ROBIN HOWARD W disposed of 23,208 shares on May 19 ’25 at a per-share price of $0.67. This resulted in the President & CEO holding 1,063,693 shares of NKTR after the transaction. In another insider transaction, Zalevsky Jonathan bought 10,712 shares at $0.67 per share on May 19 ’25.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, NKTR has a high of $22.79 and a low of $6.48.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. NKTR’s latest balance sheet shows that the firm has $733.96M in Cash & Short Term Investments as of fiscal 2021. There were $143.18M in debt and $85.20M in liabilities at the time. Its Book Value Per Share was $1.11, while its Total Shareholder’s Equity was $679.51M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NKTR is Buy with a score of 4.25.